Literature DB >> 566088

The determinants of survival following reoperation on prosthetic cardiac valves.

S Stewart, J A DeWeese.   

Abstract

In an effort to identify the determinants of survival following reoperation on patients with prosthetic cardiac valves, the experience with a group of 33 patients at the University of Rochester Medical Center was reviewed. The survival rate was 58% (19/33). Survival was not related to the valve involved, the age of the patient, or the technical hazards of a second cardiac operation. Ten (77%) of the 13 patients in New York Heart Association (NYHA) Functional Class II survived compared with 8 (40%) of the 20 in Class III or IV. The survival rate for patients with a paravalvular fistula was 79% (11/14); with valve dysfunction, 50% (6/12); and with prosthetic valve infection, 29% (2/7). The determinants of survival seem to be similar to those for primary operation (i. e., NYHA patient classification and indication for operation) and less related to the potential operative complications of a reoperation.

Entities:  

Mesh:

Year:  1978        PMID: 566088     DOI: 10.1016/s0003-4975(10)63608-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  The necessity of reoperation for patients with Bjork-Shiley, St Jude Medical, Hancock and Carpentier-Edwards prostheses.

Authors:  Y Morishita; H Toyohira; T Yuda; Y Umebayashi; H Saigenji; M Hashiguchi; K Uehara; A Taira
Journal:  Jpn J Surg       Date:  1990-07

2.  Assessment of mitral Björk-Shiley prosthetic dysfunction using digitised M mode echocardiography.

Authors:  K D Dawkins; L Cotter; D G Gibson
Journal:  Br Heart J       Date:  1984-02

Review 3.  Bioengineering aspects of heart valve replacement.

Authors:  F J Schoen; J L Titus; G M Lawrie
Journal:  Ann Biomed Eng       Date:  1982       Impact factor: 3.934

4.  Reoperation for prosthetic heart valve dysfunction: 19 years' experience.

Authors:  Z Masri; R Girardet; A Attum; R Barbie; I Yared; A Lansing
Journal:  Tex Heart Inst J       Date:  1990
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.